Abstract:Background: Evidence suggests that the beneficial effects of weight-loss diet interventions on improvement in cardiovascular risk factors may be partly through modulating secretion of adiponectin from adipose tissue. However, it remains unclear whether the long-term weight-loss diets change adiponectin levels; and how such changes, if exist, affect cardiometabolic risk. Objectives: To investigate effects of weight-loss diets with different compositions of macronutrients on long-term changes of circulating adiponectin concentrations and cardiometabolic risk factors, as well as dietary interactions with variation in the adiponectin gene. Methods: In the 2-year Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial, 811 overweight or obese adults were randomly assigned to 1 of 4 diets; the targeted percentages of energy derived from fat, protein, and carbohydrates in the 4 diets were 20, 15, and 65%; 20, 25, and 55%; 40, 15, and 45%; and 40, 25, and 35%. The current analysis was restricted to participants who had baseline plasma adiponectin measurement (n=768). Circulating adiponectin and cardiometabolic outcomes were repeatedly measured at baseline, 6 months, and 2 years. We genotyped single-nucleotide polymorphism rs266171 in the adiponectin gene. Linear mixed models were used to compare changes in adiponectin concentrations across diet groups over the intervention and predict trajectory of changes in cardiometabolic risk factors. Results: Circulating adiponectin concentrations significantly increased over 2 years, similarly in 4 weight-loss diet intervention groups. Change of plasma adiponectin was significantly associated with decreases in weight, waist circumference, triglycerides, fasting insulin, and insulin resistance measured by homeostasis model assessment of insulin resistance (HOMA-IR), and increase in HDL cholesterol, after adjusting for age, gender, ethnicity, follow-up time, diet group, and baseline level of respective outcome trait. The associations remained similar after further controlling for concurrent weight change. In addition, we observed significant interactions between rs266717 genotype and dietary fat on changes in fasting insulin and HOMA-IR (P for interaction=0.03 for both) at 6 months with adjustment for covariates. Participants who are homozygous for T allele of rs266717 had more reductions in fasting insulin and HOMA-IR than those with other genotypes in response to the high-fat diet, but such differences were not observed in the low-fat diet group. Conclusions: Regardless of macronutrient compositions, weight-loss diets beneficially increased circulating adiponectin, which was related to improvement of cardiometabolic profiles. Dietary fat intakes modified the effect of adiponectin variant rs266717 on improvement of insulin resistance.

Vitamin D Metabolism-Related Genetic Variants, Dietary Protein Intake and Improvement of Insulin Resistance in a 2 Year Weight-Loss Trial: POUNDS Lost

Abstract 14433: Dietary Protein Intake Modifies the Genetic Risk on Insulin Resistance in the Pounds Lost Trial

Circulating 25-Hydroxyvitamin D, Irs1 Variant Rs2943641, And Insulin Resistance: Replication Of A Gene- Nutrient Interaction In 4 Populations Of Different Ancestries

Genetic Determinant For Amino Acid Metabolites And Changes In Body Weight And Insulin Resistance In Response To Weight-Loss Diets The Preventing Overweight Using Novel Dietary Strategies (Pounds Lost) Trial

Genetic Susceptibility to Diabetes and Long-Term Improvement of Insulin Resistance and Β Cell Function During Weight Loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) Trial.

The Association of Gene Variants in the Vitamin D Metabolic Pathway and Its Interaction with Vitamin D on Gestational Diabetes Mellitus: A Prospective Cohort Study

Genetically Determined Vitamin D Levels and Change in Bone Density During a Weight-Loss Diet Intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial.

HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: the POUNDS Lost and DIRECT trials.

PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: the POUNDS LOST Trial

IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial.

Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity.

Genetic Variants in Vitamin D Metabolism-Related Genes and Body Mass Index: Analysis of Genome-Wide Scan Data of Approximately 7000 Chinese Women.

Modulation by dietary fat and carbohydrate of IRS1 association with type 2 diabetes traits in two populations of different ancestries.

Genetic Susceptibility, Dietary Protein Intake, and Changes of Blood Pressure: The POUNDS Lost Trial.

Dietary Protein Modifies the Effect of the MC4R Genotype on 2-Year Changes in Appetite and Food Craving: The POUNDS Lost Trial

Gut-microbiome-related LCT Genotype and 2-Year Changes in Body Composition and Fat Distribution: the POUNDS Lost Trial

Alignment of diet prescription to genotype does not promote greater weight loss success in women with obesity participating in an exercise and weight loss program

Genetic Variants at PSMD3 Interact with Dietary Fat and Carbohydrate to Modulate Insulin Resistance

Gene–Diet Interaction on Body Weight Maintenance

Abstract 47: Weight-loss Diets, Adiponectin, and Changes of Cardiometabolic Risk in the 2-Year Pounds Lost Trial

Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations During a Long-Term Weight-Loss Intervention Trial.